Vixa Skineal Cream
NDC Package 84659-9040-1

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

Identification & Billing

NDC Package Code
84659-9040-1
Package Description
15 g in 1 BOX
Product Code
11-Digit Billing Format
84659904001

Clinical Specifications

Proprietary Name
Vixa Skineal
Non-Proprietary Name
Vixa Skineal Compound Ketoconazole
Substance Name
Clobetasol Propionate; Ketoconazole; Neomycin Sulfate
Dosage Form
Cream - An emulsion, semisolid3 dosage form, usually containing > 20% water and volatiles5 and/or < 50% hydrocarbons, waxes, or polyols as the vehicle. This dosage form is generally for external application to the skin or mucous membranes.
Administration Route
Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.

Regulatory & Marketing

Labeler Name
Yunnan Yuyao Bio-pharmaceutical Co.,ltd.
Product Type
Human Prescription Drug
Marketing Category
UNAPPROVED DRUG OTHER - An unapproved drug product in a marketing category that is not reflected on a particular list.
Start Marketing Date
06-01-2024
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 84659-9040-1 identifies a specific commercial package of 15 g in 1 box of Vixa Skineal, a human prescription drug labeled by Yunnan Yuyao Bio-pharmaceutical Co.,ltd.. This cream is formulated for topical use and contains clobetasol propionate; ketoconazole; neomycin sulfate as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Yunnan Yuyao Bio-pharmaceutical Co.,ltd. on June 01, 2024. The current certification is valid through December 31, 2026.

How is this Yunnan Yuyao Bio-pharmaceutical Co.,ltd. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 84659904001. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
84659-9040-1
11-Digit CMS (5-4-2)
84659-9040-01

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.